Back to Journals » Clinical Interventions in Aging » Volume 9

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes

Total article views   Abstract views HTML views PDF downloads Totals
7,712 Dovepress* 5,323 1,216+ 1,404 6,539
PubMed Central* 0 1,173 638 1,173
Totals 5,323 2,389 2,042 7,712
*Since 4 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar